Newly Diagnosed Symptomatic Multiple Myeloma: (mSMART) Consensus Guidelines 2013

submitted by: WentzMR

Dr. Joseph Mikhael, a Hematologist from Mayo Clinic in Arizona shares results of a consensus guideline appearing in the April 2013 issue of Mayo Clinic Proceedings, which provides a rational, safe, and effective update to the changing field of multiple myeloma treatment. Available at: http://tinyurl.com/c7s3jbv

Multiple myeloma – blood cancer formed in bone marrow

submitted by: mdanderson

Multiple myeloma is a cancer caused by malignant plasma cells. Plasma cells help the human body fight infection, but when they multiply out of control, the myeloma cells overpower the bone’s healthy cells causing harmful side effects; such as bone fractures and infections. Sheeba Thomas, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses the basics, risk factors, diagnosis and treatment options for this rare cancer.

Dr Shaji K Kumar of Mayo Clinic discusses Dec 2009 Mayo Clinic Proceedings article on updated mSMART Consensus Guidelines

submitted by: mcgheekkm
Dr. Shaji K Kumar, Associate Professor of Hematology and Medicine at Mayo Clinic in Rochester, MN, discusses updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines (direct link available at http://tiny.cc/V2dk9 or visit journal at www.mayoclinicproceedings.com ). The identification of well-defined and reproducible prognostic factors and introduction of new therapies with unique modes of action and impact on disease outcome have for the first time...